Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,208 | 10 | 98.1% |
| Food and Beverage | $309.22 | 5 | 1.7% |
| Travel and Lodging | $34.40 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12,208 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $6,344 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $930.00 | 1 | Merck Sharp & Dohme LLC ($930.00) |
| 2023 | $6,344 | 7 | GlaxoSmithKline, LLC. ($6,344) |
| 2022 | $6,390 | 4 | Merck Sharp & Dohme LLC ($6,390) |
| 2020 | $1,700 | 1 | Merck Sharp & Dohme Corporation ($1,700) |
| 2019 | $1,913 | 2 | Merck Sharp & Dohme Corporation ($1,913) |
| 2018 | $1,275 | 1 | Merck Sharp & Dohme Corporation ($1,275) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/03/2024 | Merck Sharp & Dohme LLC | SIVEXTRO (Drug) | Consulting Fee | Cash or cash equivalent | $930.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/21/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| 12/15/2023 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $34.40 | General |
| 11/03/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $60.63 | General |
| 11/03/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $53.64 | General |
| 11/03/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $34.98 | General |
| 11/03/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $34.98 | General |
| 11/02/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 10/26/2022 | Merck Sharp & Dohme LLC | SIVEXTRO (Drug) | Consulting Fee | Cash or cash equivalent | $2,325.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/29/2022 | Merck Sharp & Dohme LLC | SIVEXTRO (Drug) | Consulting Fee | Cash or cash equivalent | $2,325.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/16/2022 | Merck Sharp & Dohme LLC | SIVEXTRO (Drug) | Consulting Fee | Cash or cash equivalent | $465.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/28/2022 | Merck Sharp & Dohme LLC | ZINPLAVA (Biological) | Consulting Fee | Cash or cash equivalent | $1,275.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/12/2020 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/20/2019 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/15/2019 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Consulting Fee | Cash or cash equivalent | $212.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/02/2018 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Consulting Fee | Cash or cash equivalent | $1,275.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
About Dr. Susan Coffin, M.D
Dr. Susan Coffin, M.D is a Pediatrics healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619997129.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Coffin, M.D has received a total of $18,551 in payments from pharmaceutical and medical device companies, with $930.00 received in 2024. These payments were reported across 16 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($18,208).
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Infectious Diseases
- Location Philadelphia, PA
- Active Since 07/20/2006
- Last Updated 04/19/2013
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1619997129
Products in Payments
- ZINPLAVA (Biological) $6,163
- SIVEXTRO (Drug) $6,045
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Philadelphia
Matthew Gillespie, M.d, M.D
Pediatrics — Payments: $1.5M
Stephan Grupp, M.d, M.D
Pediatrics — Payments: $472,209
Oscar Mayer, M.d, M.D
Pediatrics — Payments: $270,148
Robert Shaddy, Md, MD
Pediatrics — Payments: $148,516
Michael Levine, Md, MD
Pediatrics — Payments: $137,530
Michael Grunstein, M.d, M.D
Pediatrics — Payments: $133,646